Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL. Haeberle B, et al. Among authors: krailo m. Pediatr Blood Cancer. 2020 Aug;67(8):e28350. doi: 10.1002/pbc.28350. Epub 2020 May 8. Pediatr Blood Cancer. 2020. PMID: 32383794 Clinical Trial.
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Katzenstein HM, et al. Among authors: krailo md. J Clin Oncol. 2002 Jun 15;20(12):2789-97. doi: 10.1200/JCO.2002.06.155. J Clin Oncol. 2002. PMID: 12065555 Clinical Trial.
Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Katzenstein HM, et al. Among authors: krailo md. Cancer. 2003 Apr 15;97(8):2006-12. doi: 10.1002/cncr.11292. Cancer. 2003. PMID: 12673731 Free article. Review.
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS. Van Winkle P, et al. Among authors: krailo m. Pediatr Blood Cancer. 2005 Apr;44(4):338-47. doi: 10.1002/pbc.20227. Pediatr Blood Cancer. 2005. PMID: 15503297 Clinical Trial.
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP. Malogolowkin MH, et al. Among authors: krailo md. J Clin Oncol. 2006 Jun 20;24(18):2879-84. doi: 10.1200/JCO.2005.02.6013. J Clin Oncol. 2006. PMID: 16782927 Clinical Trial.
353 results